[1]
Ravasio, R., Pisarra, P., Porzio, R. and Comaschi, M. 2016. Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy. Global and Regional Health Technology Assessment. 3, 2 (Jul. 2016), 92–101. DOI:https://doi.org/10.33393/grhta.2016.414.